PRPDX
Price
$57.13
Change
-$0.51 (-0.88%)
Updated
Sep 6 closing price
RLBAX
Price
$34.46
Change
-$0.42 (-1.20%)
Updated
Sep 6 closing price
Ad is loading...

PRPDX vs RLBAX

Header iconPRPDX vs RLBAX Comparison
Open Charts PRPDX vs RLBAXBanner chart's image
Permanent Portfolio Permanent A
Price$57.13
Change-$0.51 (-0.88%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R1
Price$34.46
Change-$0.42 (-1.20%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PRPDX vs RLBAX Comparison Chart
Loading...
VS
PRPDX vs. RLBAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRPDX is a Buy and RLBAX is a Buy.

FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 228B vs. PRPDX (3.23B). RLBAX pays higher dividends than PRPDX: RLBAX (1.59) vs PRPDX (0.42). PRPDX was incepted earlier than RLBAX: PRPDX (8 years) vs RLBAX (22 years). RLBAX is a more actively managed with annual turnover of: 171.00 vs. PRPDX (15.26). RLBAX has a lower initial minimum investment than PRPDX: RLBAX (250) vs PRPDX (1000). RLBAX (17.92) and PRPDX (17.89) have marching annual gain over last year. PRPDX return over 5 years is better than : 46.13 vs. RLBAX (31.48).
PRPDXRLBAXPRPDX / RLBAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD12.99710.312126%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.23B228B1%
Annual Yield % from dividends0.421.5926%
Returns for 1 year17.8917.92100%
Returns for 3 years14.957.20208%
Returns for 5 years46.1331.48147%
Returns for 10 yearsN/A42.93-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IHS3.190.03
+0.95%
IHS Holding Limited
GROY1.25N/A
N/A
Gold Royalty Corp
FANG184.02-0.26
-0.14%
Diamondback Energy
CVLT148.17-0.75
-0.50%
Commvault Systems
CUE0.63-0.03
-4.65%
Cue Biopharma